Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Zfp839 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Zfp839 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ZFP839 mRNA | CTD | PMID:26251327 | acrylamide | decreases expression | ISO | Zfp839 (Mus musculus) | 6480464 | Acrylamide results in decreased expression of ZFP839 mRNA | CTD | PMID:30807115 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of ZNF839 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ZNF839 promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | Zfp839 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ZNF839 mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of ZNF839 gene | CTD | PMID:31601247 | chlordecone | multiple interactions | ISO | Zfp839 (Mus musculus) | 6480464 | Chlordecone inhibits the reaction [Biomarkers metabolite binds to ZFP839 gene] | CTD | PMID:31084621 | chlorpyrifos | decreases expression | ISO | Zfp839 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of ZFP839 mRNA | CTD | PMID:37019170 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ZNF839 mRNA | CTD | PMID:19549813 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ZNF839 mRNA | CTD | PMID:29803840 | elemental selenium | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of ZNF839 mRNA | CTD | PMID:19244175 | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of ZNF839 protein | CTD | PMID:37730182 | gentamycin | decreases expression | ISO | Zfp839 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ZFP839 mRNA | CTD | PMID:33387578 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of ZNF839 mRNA | CTD | PMID:28988120 | methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of ZNF839 mRNA | CTD | PMID:24449571 | paracetamol | decreases expression | ISO | Zfp839 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of ZFP839 mRNA | CTD | PMID:33387578 | potassium dichromate | decreases expression | ISO | Zfp839 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of ZFP839 mRNA | CTD | PMID:23608068 | selenium atom | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of ZNF839 mRNA | CTD | PMID:19244175 | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of ZNF839 mRNA | CTD | PMID:31758290 | titanium dioxide | increases expression | ISO | Zfp839 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of ZFP839 mRNA | CTD | PMID:29264374 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of ZNF839 mRNA | CTD | PMID:28818685 | vitamin E | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of ZNF839 mRNA | CTD | PMID:19244175 | |